Literature DB >> 16104461

Clinical profile of dengue hemorrhagic fever cases in Mexico.

Joel Navarrete-Espinosa1, Héctor Gómez-Dantés, Juan Germán Celis-Quintal, José Luis Vázquez-Martínez.   

Abstract

OBJECTIVE: Dengue hemorrhagic fever is a public health problem in Mexico since 1994. With four serotypes circulating the risk of epidemic dengue hemorrhagic fever is increasing.
MATERIAL AND METHODS: We describe the clinical features of confirmed cases in the social security health system (IMSS) from 1995 to 2003. Clinical picture and epidemiological features were compared and a multivariate model was fitted to evaluate associations.
RESULTS: Cases were divided into two groups: 438 patients with dengue fever, including 109 cases with hemorrhagic manifestations without thrombocytopenia, and 977 cases with dengue hemorrhagic fever, including 79 deaths. The main risk factors associated with mortality were hematemesis (RR 2.6; CI 95% 1.4-4.6) and melena (RR 2.2; Cl 95% 1.2-3.7).
CONCLUSIONS: Our results characterize the clinical profile of dengue hemorrhagic fever cases in Mexico and identify prognostic factors to alert clinician for the prevention of a fatal evolution.

Entities:  

Mesh:

Year:  2005        PMID: 16104461     DOI: 10.1590/s0036-36342005000300002

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  8 in total

1.  Economic and disease burden of dengue in Mexico.

Authors:  Eduardo A Undurraga; Miguel Betancourt-Cravioto; José Ramos-Castañeda; Ruth Martínez-Vega; Jorge Méndez-Galván; Duane J Gubler; María G Guzmán; Scott B Halstead; Eva Harris; Pablo Kuri-Morales; Roberto Tapia-Conyer; Donald S Shepard
Journal:  PLoS Negl Trop Dis       Date:  2015-03-18

Review 2.  Epidemiological trends of dengue disease in Mexico (2000-2011): a systematic literature search and analysis.

Authors:  Héctor Gómez Dantés; José Arturo Farfán-Ale; Elsa Sarti
Journal:  PLoS Negl Trop Dis       Date:  2014-11-06

3.  Dengue fever seroprevalence and risk factors, Texas-Mexico border, 2004.

Authors:  Joan Marie Brunkard; Jose Luis Robles López; Josue Ramirez; Enrique Cifuentes; Stephen J Rothenberg; Elizabeth A Hunsperger; Chester G Moore; Regina M Brussolo; Norma A Villarreal; Brent M Haddad
Journal:  Emerg Infect Dis       Date:  2007-10       Impact factor: 6.883

4.  Specific genetic markers for detecting subtypes of dengue virus serotype-2 in isolates from the states of Oaxaca and Veracruz, Mexico.

Authors:  Catalina E Gardella-Garcia; Gerardo Perez-Ramirez; Joel Navarrete-Espinosa; Alejandro Cisneros; Fabiola Jimenez-Rojas; Luis R Ramírez-Palacios; Rocio Rosado-Leon; Minerva Camacho-Nuez; Maria de L Munoz
Journal:  BMC Microbiol       Date:  2008-07-15       Impact factor: 3.605

Review 5.  Why are people with dengue dying? A scoping review of determinants for dengue mortality.

Authors:  Mabel Carabali; Libia Milena Hernandez; Maria Jose Arauz; Luis Angel Villar; Valéry Ridde
Journal:  BMC Infect Dis       Date:  2015-07-30       Impact factor: 3.090

6.  Risk factors for fatality among confirmed adult dengue inpatients in Singapore: a matched case-control study.

Authors:  Tun-Linn Thein; Yee-Sin Leo; Dale A Fisher; Jenny G Low; Helen M L Oh; Victor C Gan; Joshua G X Wong; David C Lye
Journal:  PLoS One       Date:  2013-11-22       Impact factor: 3.240

7.  Primary dengue virus infections induce differential cytokine production in Mexican patients.

Authors:  Sergio Isaac de la Cruz Hernández; Henry Nelson Puerta-Guardo; Hilario Flores Aguilar; Silvia González Mateos; Irma López Martinez; Vianney Ortiz-Navarrete; Juan E Ludert; Rosa María del Angel
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-03       Impact factor: 2.743

8.  Management and outcomes of severe dengue patients presenting with sepsis in a tropical country.

Authors:  Prapit Teparrukkul; Viriya Hantrakun; Nicholas P J Day; T Eoin West; Direk Limmathurotsakul
Journal:  PLoS One       Date:  2017-04-24       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.